Back
Arcturus Therapeutics Holdings Stock Price Chart
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
19
ARCT
Arcturus Therapeutics Holdings
Last Price:
$11.59
Seasonality Move:
30.96%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARCT is experiencing slight selling pressure.
Arcturus Therapeutics Holdings Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.59 | Sell |
| 20-day SMA: | 13.93 | Sell |
| 50-day SMA: | 15.63 | Sell |
| 200-day SMA: | 19.66 | Sell |
| 8-day EMA: | 12.55 | Sell |
| 20-day EMA: | 13.7 | Sell |
| 50-day EMA: | 15.21 | Sell |
| 200-day EMA: | 19.53 | Sell |
Arcturus Therapeutics Holdings Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.13 | Sell |
| Relative Strength Index (14 RSI): | 30.22 | Sell |
| Chaikin Money Flow: | -143937 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.77 - 16.19) | Sell |
| Bollinger Bands (100): | (14.82 - 18.46) | Sell |
Arcturus Therapeutics Holdings Technical Analysis
| Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Arcturus Therapeutics Holdings Stock
Is Arcturus Therapeutics Holdings Stock a Buy?
-
Arcturus Therapeutics Holdings share price is 11.58 while ARCT 8-day simple moving average is 12.59, which is a Sell signal.
-
The stock price of ARCT is 11.58 while Arcturus Therapeutics Holdings 20-day SMA is 13.93, which makes it a Sell.
-
Arcturus Therapeutics Holdings 50-day simple moving average is 15.63 while ARCT share price is 11.58, making it a Sell technically.
-
ARCT stock price is 11.58 and Arcturus Therapeutics Holdings 200-day simple moving average is 19.66, creating a Sell signal.
ARCT Technical Analysis vs Fundamental Analysis
Sell
19
Arcturus Therapeutics Holdings (ARCT)
is a Sell
Is Arcturus Therapeutics Holdings a Buy or a Sell?
-
Arcturus Therapeutics Holdings stock is rated a SellThe current Arcturus Therapeutics Holdings [ARCT] share price is $11.58. The Score for ARCT is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
Arcturus Therapeutics Holdings Stock Info
Market Cap:
314M
Price in USD:
11.58
Share Volume:
311K
Arcturus Therapeutics Holdings 52-Week Range
52-Week High:
45.00
52-Week Low:
11.39
Sell
19
Arcturus Therapeutics Holdings (ARCT)
is a Sell
Arcturus Therapeutics Holdings Share Price Forecast
-
What is the Arcturus Therapeutics Holdings stock price today?The Arcturus Therapeutics Holdings stock price is 11.58 USD today.
-
Will ARCT stock go up or go down?Arcturus Therapeutics Holdings> share price is forecast to RISE/FALL based on technical indicators
-
Is Arcturus Therapeutics Holdings overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Arcturus Therapeutics Holdings is overvalued.
Is Arcturus Therapeutics Holdings Stock a Buy?
-
Arcturus Therapeutics Holdings share price is 11.58 while ARCT 8-day exponential moving average is 12.55, which is a Sell signal.
-
The stock price of ARCT is 11.58 while Arcturus Therapeutics Holdings 20-day EMA is 13.70, which makes it a Sell.
-
Arcturus Therapeutics Holdings 50-day exponential moving average is 15.21 while ARCT share price is 11.58, making it a Sell technically.
-
ARCT stock price is 11.58 and Arcturus Therapeutics Holdings 200-day simple moving average is 19.53, creating a Sell signal.
Fundamental Analysis of Arcturus Therapeutics Holdings
Is Arcturus Therapeutics Holdings a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.20 per share, a decrease next quarter of $0.14 per share, a decrease this year of $2.40 per share, and an increase next year of $0.98 per share.
Technical Analysis of Arcturus Therapeutics Holdings
Should I short Arcturus Therapeutics Holdings stock?
-
ARCT Moving Average Covergence Divergence (MACD) indicator is -1.13, suggesting Arcturus Therapeutics Holdings is a Sell
-
Arcturus Therapeutics Holdings Relative Strength Index (RSI) is 30.22, which suggest Arcturus Therapeutics Holdings is oversold
-
The Bollinger Bands (25) for Arcturus Therapeutics Holdings is (12.77 - 16.19), which suggest Arcturus Therapeutics Holdings is a Sell
-
The Bollinger Bands (100) for Arcturus Therapeutics Holdings is (14.82 - 18.46), which suggest Arcturus Therapeutics Holdings is a Sell
* Arcturus Therapeutics Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.